Trial Profile
Secondary prevention of osteoporosis: a window of opportunity in the acute rehabilitation setting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid/colecalciferol (Primary) ; Calcitriol receptor agonists; Calcium carbonate; Colecalciferol
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- 28 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2007 New trial record.